Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways
Qing‐Qing Fang(Sir Run Run Shaw Hospital), Wei‐Qiang Tan(King's College London)
Cited by 64
Related Papers
Angiotensin‐converting enzyme inhibitor works as a scar formation inhibitor by down‐regulating Smad and TGF‐β‐activated kinase 1 (TAK1) pathways in mice
|British Journal of Pharmacology|2018|58
A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma
|Frontiers in Immunology|2020|35
The compound losartan cream inhibits scar formation via TGF-β/Smad pathway
|Scientific Reports|2022|12